{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T19:24:10Z","timestamp":1781724250210,"version":"3.54.5"},"reference-count":43,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1016\/j.canlet.2012.02.029","type":"journal-article","created":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T04:09:25Z","timestamp":1330574965000},"page":"159-168","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Bax345\/BLyS: A novel, completely human fusion protein targeting malignant B cells and delivering a unique mitochondrial toxin"],"prefix":"10.1016","volume":"322","author":[{"given":"Mi-Ae","family":"Lyu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence H.","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter N.","family":"Hittelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John W.","family":"Marks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Jeong","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael G.","family":"Rosenblum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2012.02.029_b0005","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1101\/gad.13.15.1899","article-title":"Bcl-2 family members and the mitochondria in apoptosis","volume":"13","author":"Gross","year":"1999","journal-title":"Genes & Dev"},{"key":"10.1016\/j.canlet.2012.02.029_b0010","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.bbamcr.2003.08.012","article-title":"Structural biology of the Bcl-2 family of proteins","volume":"1644","author":"Petros","year":"2004","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.canlet.2012.02.029_b0015","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/0092-8674(93)90509-O","article-title":"Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death","volume":"74","author":"Oltvai","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2012.02.029_b0020","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0168-9525(00)89010-1","article-title":"Regulators of cell death","volume":"11","author":"Korsmeyer","year":"1995","journal-title":"Trends Genet."},{"key":"10.1016\/j.canlet.2012.02.029_b0025","doi-asserted-by":"crossref","first-page":"3878","DOI":"10.1093\/emboj\/17.14.3878","article-title":"Enforced dimerization of BAX results in its translocation, mitochondrial dysfunction and apoptosis","volume":"17","author":"Gross","year":"1998","journal-title":"EMBO J."},{"key":"10.1016\/j.canlet.2012.02.029_b0030","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S1097-2765(01)00320-3","article-title":"BCL-2, BCL-XL sequester BH3 domain-only molecules preventing BAX- and BAK-mediated mitochondrial apoptosis","volume":"8","author":"Cheng","year":"2001","journal-title":"Mol. Cell"},{"key":"10.1016\/j.canlet.2012.02.029_b0035","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1126\/science.1059108","article-title":"Proapoptotic Bax and Bak: a requisite gateway to mitochondrial dysfunction and death","volume":"292","author":"Wei","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.canlet.2012.02.029_b0040","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.ceb.2005.10.001","article-title":"Life in the balance: How BH3-only proteins induce apoptosis","volume":"17","author":"Willis","year":"2005","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.canlet.2012.02.029_b0045","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1101\/gad.1553607","article-title":"A three-helix homo-oligomerization domain containing BH3 and BH1 is responsible for the apoptotic activity of Bax","volume":"21","author":"George","year":"2007","journal-title":"Genes & Dev"},{"key":"10.1016\/j.canlet.2012.02.029_b0050","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1042\/bj20031152","article-title":"Bax-induced cytochrome c release from mitochondria depends on \u03b1-helices-5 and -6","volume":"378","author":"Heimlich","year":"2004","journal-title":"Biochem. J."},{"key":"10.1016\/j.canlet.2012.02.029_b0055","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1126\/science.1061965","article-title":"BAFF-R, a newly identified TNF receptor that specifically interacts with BAFF","volume":"293","author":"Thompson","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.canlet.2012.02.029_b0060","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1126\/science.278.5335.138","article-title":"NFAT activation induced by a CAML-interacting member of the tumor necrosis factor receptor superfamily","volume":"278","author":"von Bulow","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.canlet.2012.02.029_b0065","doi-asserted-by":"crossref","first-page":"3897","DOI":"10.1002\/j.1460-2075.1992.tb05482.x","article-title":"A new gene, BCM, on chromosome 16 is fused to the interleukin 2 gene by a t(4;16)(q26;p13) translocation in a malignant T cell lymphoma","volume":"11","author":"La\u00e2bi","year":"1992","journal-title":"EMBO J."},{"key":"10.1016\/j.canlet.2012.02.029_b0070","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.4049\/jimmunol.172.5.3268","article-title":"Lymphoma B cells evade apoptosis through the TNF family members BAFF\/BLyS and April","volume":"172","author":"He","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.canlet.2012.02.029_b0075","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1182\/blood-2002-02-0558","article-title":"Aberrant expression of B-lymphocyte stimulator by B chronic leukemia cells: a mechanism for survival","volume":"100","author":"Novak","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2012.02.029_b0080","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1182\/blood-2004-02-0762","article-title":"Expression of BLyS and its receptors in B-cell non-Hodgkin lymphoma: correlation with disease activity and patient outcome","volume":"104","author":"Novak","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2012.02.029_b0085","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s00428-005-1275-6","article-title":"Expression of BAFF-R (BR3) in normal and neoplastic lymphoid tissues characterized with a newly developed monoclonal antibody","volume":"447","author":"Nakamura","year":"2005","journal-title":"Virchows Arch."},{"key":"10.1016\/j.canlet.2012.02.029_b0090","first-page":"483","article-title":"Current approaches to the management of non-Hodgkin\u2019s lymphoma","volume":"25","author":"Vose","year":"1998","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.canlet.2012.02.029_b0095","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1056\/NEJMoa012914","article-title":"The use of molecular profiling to predict survival after chemotherapy for diffuse large B-cell lymphoma","volume":"346","author":"Rosenwald","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canlet.2012.02.029_b0100","doi-asserted-by":"crossref","first-page":"9991","DOI":"10.1073\/pnas.1732008100","article-title":"A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma","volume":"100","author":"Wright","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.canlet.2012.02.029_b0105","doi-asserted-by":"crossref","first-page":"7013","DOI":"10.1200\/JCO.2005.01.1825","article-title":"High rate of durable remission after treatment of newly diagnosed aggressive mantle-cell lymphoma with rituximab plus hyper-CVAD alternating with rituximab plus high-dose methotrexate and cytarabine","volume":"23","author":"Romaguera","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2012.02.029_b0110","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/nrc2230","article-title":"Genetic and molecular pathogenesis of mantle cell lymphoma: perspectives for new targeted therapeutics","volume":"7","author":"Jares","year":"2007","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2012.02.029_b0115","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1158\/1535-7163.MCT-06-0254","article-title":"The rGel\/BLyS fusion toxin specifically targets malignant B cells expressing the BLyS receptors BAFF-R, TACI, and BCMA","volume":"6","author":"Lyu","year":"2007","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.canlet.2012.02.029_b0120","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1182\/blood-2006-08-042424","article-title":"The growth factor fusion construct containing B-lymphocyte stimulator (BLyS) and the toxin rGel induces apoptosis specifically in BAFF-R-positive CLL cells","volume":"109","author":"Nimmanapalli","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2012.02.029_b0125","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1593\/neo.91960","article-title":"The rGel\/BLyS fusion toxin inhibits diffuse large B-cell lymphoma growth in vitro and in vivo","volume":"12","author":"Lyu","year":"2010","journal-title":"Neoplasia"},{"key":"10.1016\/j.canlet.2012.02.029_b0130","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/j.bcp.2010.07.017","article-title":"The rGel\/BLyS fusion toxin inhibits STAT3 signaling via down-regulation of interleukin-6 receptor in diffuse large B-cell lymphoma","volume":"80","author":"Lyu","year":"2010","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.canlet.2012.02.029_b0135","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/35000501","article-title":"Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling","volume":"403","author":"Alizadeh","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2012.02.029_b0140","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1084\/jem.194.12.1861","article-title":"Constitutive nuclear factor kappa B activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells","volume":"194","author":"Davis","year":"2001","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.canlet.2012.02.029_b0145","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.cancergencyto.2007.10.008","article-title":"Coordinated expression of microRNA-155 and predicted target genes in diffuse large B-cell lymphoma","volume":"181","author":"Rai","year":"2008","journal-title":"Cancer Genet. Cytogenet."},{"key":"10.1016\/j.canlet.2012.02.029_b0150","doi-asserted-by":"crossref","first-page":"424","DOI":"10.5858\/2003-127-0424-COMCLC","article-title":"Characterization of 4 mantle cell lymphoma cell lines","volume":"127","author":"Amin","year":"2003","journal-title":"Arch. Pathol. Lab."},{"key":"10.1016\/j.canlet.2012.02.029_b0155","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0378-1119(89)90358-2","article-title":"Site-directed mutagenesis by overlap extension using the polymerase chain reaction","volume":"77","author":"Ho","year":"1989","journal-title":"Gene"},{"key":"10.1016\/j.canlet.2012.02.029_b0160","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1093\/protein\/6.8.989","article-title":"An improved linker for single-chain Fv with reduced aggregation and enhanced proteolytic stability","volume":"6","author":"Whitlow","year":"1993","journal-title":"Protein Eng."},{"key":"10.1016\/j.canlet.2012.02.029_b0165","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1158\/1535-7163.MCT-05-0014","article-title":"The immunocytokine scFv23\/TNF sensitizes HER-2\/neu-overexpressing SKBR-3 cells to tumor necrosis factor (TNF) via up-regulation of TNF receptor-1","volume":"4","author":"Lyu","year":"2005","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.canlet.2012.02.029_b0170","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/nsb769","article-title":"Structural basis of BLyS receptor recognition","volume":"9","author":"Oren","year":"2002","journal-title":"Nat. Struct. Biol."},{"key":"10.1016\/j.canlet.2012.02.029_b0175","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0092-8674(00)00167-7","article-title":"Structural of Bax: coregulation of dimer formation and intracellular localization","volume":"103","author":"Suzuki","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2012.02.029_b0180","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0014-5793(99)01050-9","article-title":"Interleukin 2-Bax: a novel prototype of human chimeric proteins for targeted therapy","volume":"457","author":"Aqeilan","year":"1999","journal-title":"FEBS Lett."},{"key":"10.1016\/j.canlet.2012.02.029_b0185","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1006\/prep.1997.0871","article-title":"Purification and biochemical properties of soluble recombinant human Bax","volume":"13","author":"Lewis","year":"1998","journal-title":"Protein Exp. Purif."},{"key":"10.1016\/j.canlet.2012.02.029_b0190","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1006\/prep.1998.1010","article-title":"Expression and purification of full-length human Bax \u03b1","volume":"15","author":"Montessuit","year":"1999","journal-title":"Protein Exp. Purif."},{"key":"10.1016\/j.canlet.2012.02.029_b0195","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1126\/science.1206727","article-title":"Pretreatment mitochondrial priming correlates with clinical response to cytotoxic chemotherapy","volume":"334","author":"Chonghaile","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.canlet.2012.02.029_b0200","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1158\/1535-7163.23.4.1","article-title":"(\u2212)-Gossypol acts directly on the mitochondria to overcome Bcl-2- and Bcl-XL-mediated apoptosis resistance.","volume":"4","author":"Oliver","year":"2005","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.canlet.2012.02.029_b0205","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1182\/blood-2007-12-126946","article-title":"Gossypol, a BH3 mimetic, induces apoptosis in chronic lymphocytic leukemia cells","volume":"112","author":"Balakrishnan","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2012.02.029_b0210","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nature02067","article-title":"Development and maintenance of B and T lymphocytes requires anti-apoptotic Mcl-1","volume":"426","author":"Opfeman","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2012.02.029_b0215","doi-asserted-by":"crossref","first-page":"3379","DOI":"10.1182\/blood.V91.9.3379","article-title":"Expression of apoptosis-regulating proteins in chronic lymphocytic leukemia: correlation with in vitro and in vivo chemoresponses","volume":"91","author":"Kitada","year":"1998","journal-title":"Blood"}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383512001401?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383512001401?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T15:33:47Z","timestamp":1759592027000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383512001401"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["S0304383512001401"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2012.02.029","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bax345\/BLyS: A novel, completely human fusion protein targeting malignant B cells and delivering a unique mitochondrial toxin","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2012.02.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}